Labiotech.eu

Interview 9 May 2019

A 20-Year Journey to Nail Down an Undruggable Cancer Target

The ultimate goal of cancer research is to bring to the market a drug that improves the treatment of patients lacking options. Laura Soucek, CEO of the startup Peptomyc, shares the story of her journey to take a cancer treatment against an until now undruggable target to the clinic. It all started when Soucek was […]

May 9, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

achondroplasia pfizer therachon acquisition

More News! 9 May 2019

Pfizer Pays up to €700M to Acquire Swiss Biotech Restoring Bone Growth in Achondroplasia

Pharma giant Pfizer is acquiring the Swiss biotech Therachon, which is developing a protein drug to boost bone growth in the genetic condition achondroplasia. Pfizer will pay €303M ($340M) upfront, and up to €420M ($470M) dependent on Therachon reaching milestones in the development of its drug improving bone growth in achondroplasia. This genetic condition inhibits […]

May 9, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 8 May 2019

Schizophrenia Treatments Could be Tested and Personalized Using Patients’ Blood

Scientists at the University of Cambridge have developed a way to screen treatments for schizophrenia on single cells from a patient’s blood sample, which could speed up drug discovery and help to personalize treatments for people with the condition. Around 21 million people worldwide suffer from schizophrenia, and this is likely to get worse with […]

May 8, 2019 - 2 minutesmins - By Jonathan Smith

Expert Advice 8 May 2019

Why It’s Important to “Think Big” When Raising Money for Your Company

There are not many people who can say they led one of Europe’s largest biotechs and launched the first approved gene therapy in Europe. Joern Aldag, now CEO at Austrian biotech Hookipa Pharma, has done both. Aldag got into biotech because he wanted to use his entrepreneurial skills to advance medicine. After 9 years of […]

May 8, 2019 - 9 minutesmins - By Helen Albert

Best in Biotech 8 May 2019

Top 10 Biotechs in Lausanne

The Swiss city of Lausanne is perhaps best known as a hub of international sport, but what many outsiders may not realize is that it’s also one of Switzerland’s biggest biotech hubs. Many of the biotechs in the city are connected to the University of Lausanne (UNIL), as well as the renowned Swiss Federal Institute […]

May 8, 2019 - 7 minutesmins - By David Cox

News and Trends 7 May 2019

Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets

Confo Therapeutics has raised €30M in a Series A round that will take its unique technology to find drugs for historically undruggable targets to clinical trials. The fundraising was led by the VCs BioGeneration Ventures and Wellington Partners, and joined by several other private and public investors. With the money, Confo Therapeutics aims to […]

May 7, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

bees dying university of Cambridge vaccine virus

News and Trends 6 May 2019

Molecules in Bee Jelly Could Protect Whole Nests Against Viruses for Generations

A research team has discovered that honeybees pass molecules of RNA to each other by sharing it in edible jelly, which could lead to vaccines that can stop generations of bees from dying from viral infections. Honeybees don’t just give us honey. As the dominant pollinators of lots of food crops, around a third of […]

May 6, 2019 - 2 minutesmins - By Jonathan Smith

Interview 6 May 2019

2019 Will Be a “Year of Realism” for Biotech Investments

Biotech investors regularly jump on new crazes, including the microbiome and CRISPR-Cas9 gene editing. At BIO-Europe Spring 2019, Regina Hodits, Managing Partner at German VC firm Wellington Partners Life Sciences, spoke to us about the firm’s realistic approach to biotech investment. Biotechnology is an industry with high risks and high rewards. Before a medical biotech […]

May 6, 2019 - 6 minutesmins - By Jonathan Smith

combioxin antibiotic resistance pneumonia

News and Trends 3 May 2019

Drug Mopping Up Bacterial Toxins Shows Potential to Tackle Antibiotic Resistance in Phase I

An antibiotic-enhancing drug developed by the Swiss biotech Combioxin to tackle antibiotic resistance showed promising effects in a phase I trial. Antibiotic resistance is a growing problem around the world, causing common infections such as pneumonia to become harder to treat. As standard antibiotics become less and less effective, we urgently need to find new […]

May 3, 2019 - 2 minutesmins - By Jonathan Smith

green basilisk self healing concrete delft

Startup Scout 3 May 2019

This Biotech Makes Self-Healing Concrete Using Bacteria

Imagine walls and buildings that heal themselves just like your skin does. The Dutch biotech Green Basilisk is making this idea a reality by embedding special limestone-producing bacteria into concrete. Mission: To make concrete that can heal cracks and other kinds of damage using bacteria. This self-healing power cuts the maintenance the material requires, and […]

May 3, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 2 May 2019

Drug for Autoimmune Liver Disease Yields Mixed Results in Hard-to-Treat Patients

Developed by the French biotech Genkyotex, a first-in-class treatment for the liver disease primary biliary cholangitis failed to reduce a key disease biomarker in a phase II trial, but showed potential for reducing liver scarring. Primary biliary cholangitis is an autoimmune disease that damages the liver and can lead to liver scarring (fibrosis) or the […]

May 2, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 1 May 2019

UK Genome Diagnostics Biotech Closes €27M Series B to Support NHS

Cambridge-based Congenica has closed a €27M (£23.3M) series B fundraising round to support the use of its rare disease diagnostics platform by the newly formed NHS Genomic Medicine Service, as well as to allow the company to expand internationally. The genomics diagnostic company received a €15.5M (£13.3M) investment, led by the London-based fund management firm […]

May 1, 2019 - 2 minutesmins - By Helen Albert

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

A 20-Year Journey to Nail Down an Undruggable Cancer Target

Pfizer Pays up to €700M to Acquire Swiss Biotech Restoring Bone Growth in Achondroplasia

Schizophrenia Treatments Could be Tested and Personalized Using Patients’ Blood

Why It’s Important to “Think Big” When Raising Money for Your Company

Top 10 Biotechs in Lausanne

Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets

Molecules in Bee Jelly Could Protect Whole Nests Against Viruses for Generations

2019 Will Be a “Year of Realism” for Biotech Investments

Drug Mopping Up Bacterial Toxins Shows Potential to Tackle Antibiotic Resistance in Phase I

This Biotech Makes Self-Healing Concrete Using Bacteria

Drug for Autoimmune Liver Disease Yields Mixed Results in Hard-to-Treat Patients

UK Genome Diagnostics Biotech Closes €27M Series B to Support NHS

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!